Infusion of angiotensin-II analogue in two patients with unilateral renovascular hypertension.
D000328:Adult; D000409:Alanine / Q000008:administration & dosage; D000450:Aldosterone / Q000652:urine; D000804:Angiotensin II / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006977:Hypertension, Renal / Q000188:drug therapy* / Q000503:physiopathology / Q000601:surgery; D007263:Infusions, Parenteral; D008297:Male; D010953:Plasma Volume; D011182:Postoperative Care; D011188:Potassium / Q000097:blood / Q000652:urine; D011300:Preoperative Care; D012078:Renal Artery Obstruction / Q000150:complications*; D012082:Renal Veins / Q000503:physiopathology; D012521:Sarcosine / Q000008:administration & dosage; D012964:Sodium / Q000378:metabolism; D013997:Time Factors; D014655:Vascular Resistance / Q000187:drug effects
D000804:Angiotensin II; D000450:Aldosterone; D012964:Sodium; D000409:Alanine; D011188:Potassium; D012521:Sarcosine